Furthermore, maintenance of AT1R and AT2R balance via external modulations with AT1R blockage or hormonal replacement therapy-based AT2R upregulation was shown to be beneficial in PD (Farag et al., 2017). The gene discussed is AGTR1; the disease is Parkinson disease.